Scientists develop the first blood test for melanoma detection
The new blood test detects the autoantibodies produced in the body in response to the melanoma. Scientists at the Edith…
VarmX Raises € 12.5 Million to Develop Modified Blood Coagulation Factor X for Treating Severe Bleeding in Patients Using Anti-Coagulants Funding enables clinical stage trials of lead compound PseudoXa
€ 7.5 million Series A financing from lead investor BioGeneration Ventures (BGV) and Dutch regional development company InnovationQuarter Financing supplemented…
Significant blood sugar improvement with Xultophy® compared to insulin glargine U-100 when used as add-on to oral diabetes medications
Adults with type 2 diabetes treated with Xultophy® (insulin degludec and liraglutide injection) also experienced no change in body weight,…
Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial
Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in…
Proteomics and Dimerix partner to improve the treatment of kidney disease
Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein…